Synbio Technologies provides protein expression services in four expression systems: Bacterial, yeast, Insect and mammalian. We provide customized services for scientists all over the world. From milligram to kilogram scale, our synthetic biology platform and NG Condon optimization technology produces high purity active proteins that will accelerate your research. Depending on the nature of the protein in question and the customer’s specific requirements, we carefully select from a range of expression vectors, expression hosts, and fusion tags to offer the best possible outcome.
Our primary focus is on the production of high-quality proteins that not only meet but exceed our customers’ expectations, resulting in significant cost savings measured in both time and money. We utilize cutting-edge technologies and expertise in protein engineering to ensure a superior product every time. Rest assured that when you choose our services, you are selecting a team of professionals dedicated to excellence in protein production.
 Leader B, Baca Q J, Golan D E. Protein therapeutics: a summary and pharmacological classification[J]. Nature reviews Drug discovery, 2008, 7(1): 21-39.
 Silpa S, Janet B X, Rupachandra S. (2023). Emerging Trends, Challenges, and Opportunities in Protein Therapeutics. In Dev B S, Timir T (Eds.), Protein-based Therapeutics (pp. 297-324).